NIH-funded research R03 grant

Developing new MRI contrast agents using iron coordination cages

Official title: Octahedral iron coordination cages as T1 MRI probes

Funded at State University of New York at Buffalo · NIH-11116076 · Data updated 2026-11-12

This study is looking at new MRI contrast agents made from iron instead of the usual gadolinium, aiming to create safer and better options for people needing MRI scans by improving how well the images show up.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionState University of New York at Buffalo
NIH-funded
Lab location1 site (Amherst, United States)
Project startJanuary 10, 2025
Project endDecember 31, 2026
Funding year2025
Award (this year)$79,001
NIH project number1R03EB037086-01
Project IDNIH-11116076 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals requiring MRI scans who may benefit from improved contrast agents, particularly those with allergies or sensitivities to gadolinium.

Less likely to help

Patients who do not require MRI imaging or who are not affected by gadolinium-based contrast agents may not benefit from this research.

What this research studies

This research focuses on creating innovative MRI contrast agents that utilize iron instead of traditional gadolinium-based agents. The approach involves designing self-assembled iron coordination cages that are stable in water and can enhance MRI imaging by improving the relaxation times of protons. The study will explore various chemical modifications to increase the solubility and effectiveness of these agents, including the addition of amino acids and other functional groups. By characterizing these new compounds through advanced techniques, the research aims to provide safer and more effective options for MRI imaging.

Why it matters

Potential benefit: If successful, this research could lead to safer MRI contrast agents that reduce the risk of adverse reactions associated with gadolinium.

How similar studies have gone: While the use of iron-based agents in MRI is a developing area, there have been promising results in similar research exploring alternative contrast agents.

Where this research is happening

  • State University of New York at Buffalo
    Amherst, United States
    Active

Researchers

  • Principal investigator: Morrow, Janet Ruth — State University of New York at Buffalo
  • Study coordinator: Morrow, Janet Ruth

Related research

Other NIH-funded projects on the same topics.

  • Improving population health by studying reproductive health and development.

    This study is looking at how different factors, like the environment and genetics, affect the health of pregnant women and people of reproductive age, with the goal of improving pregnancy outcomes and the health of children as they grow up.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-9795452

  • How noise and hearing loss affect the first step of hearing in the brain

    This NIH grant studies how noise and conductive hearing loss change the intimate connections between auditory nerves and brain cells, which could influence how we hear in noisy environments.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11620270

  • Programmable hydrogels to protect transplanted human OPCs in demyelinating disease

    Aims to improve survival and integration of transplanted human oligodendrocyte precursor cells by using specially designed hydrogels to reduce cell death during delivery in demyelinating diseases like multiple sclerosis.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11579956

  • How a mouth bacterium might fuel gum disease and heart risk

    A small study will look at how a bacterium in the mouth that makes a reactive chemical (methylglyoxal) could drive gum inflammation and changes in the mouth’s bacteria, possibly linking to heart disease.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11564245

  • New dual-acting treatments against tough Klebsiella pneumoniae infections

    A new funding opportunity aims to develop therapies that both fight and disarm the dangerous Klebsiella pneumoniae bacteria, especially strains that resist many drugs, to help patients with serious infections.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11563773

  • Muscle health and aging in postmenopausal women

    This NIH grant supports a study in older, postmenopausal women to understand how insulin and blood sugar relate to muscle loss over time and whether this differs by race/ethnicity.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11532334

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.